Cargando…
Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury
BACKGROUND: Fenoldopam mesylate is a selective agonist of DA-1 receptors. It is currently used for the in-hospital treatment of severe hypertension. DA-1 receptors have high density in renal pa-renchyma and for this reason, a possible reno-protective role of Fenoldopam mesylate was investigated. MET...
Autores principales: | Noce, Annalisa, Marrone, Giulia, Rovella, Valentina, Busca, Andrea, Gola, Caterina, Ferrannini, Michele, Di Daniele, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751352/ https://www.ncbi.nlm.nih.gov/pubmed/31038062 http://dx.doi.org/10.2174/1389201020666190417124711 |
Ejemplares similares
-
Can Serum Cystatin C predict long-term survival in cardiac surgery patients?
por: Rovella, Valentina, et al.
Publicado: (2018) -
Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients
por: Hammer, Gregory B, et al.
Publicado: (2008) -
Fenoldopam Mesylate Enhances the Survival of Mesenchymal Stem Cells Under Oxidative Stress and Increases the Therapeutic Function in Acute Kidney Injury
por: Jo, Seo Yeon, et al.
Publicado: (2023) -
MOSH Syndrome (Male Obesity Secondary Hypogonadism): Clinical Assessment and Possible Therapeutic Approaches
por: De Lorenzo, Antonino, et al.
Publicado: (2018) -
Erythrocyte glutathione transferase in kidney transplantation: a probe for kidney detoxification efficiency
por: Bocedi, Alessio, et al.
Publicado: (2018)